Check-Cap Ltd. (MBAI)
NCM · Healthcare · Diagnostics & Research
$1.04
-0.95%
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
Market Cap
$8.0M
Shares Outstanding
7.7M
Exchange
NCM
Currency
USD
About Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -20.0M | -17.8M | -9.5M | -2.4M |
| Net Income | -19.1M | -17.6M | -25.1M | 4.1M |
| Diluted EPS | $-3.37 | $-3.00 | $-4.30 | $0.66 |